May 11, 2022 / 07:00PM GMT
Tazeen Ahmad - BofA Securities, Research Division - MD in Equity Research & Research Analyst
Good afternoon, and welcome to the Bank of America Healthcare Conference. I am Tazeen Ahmad. I'm one of the senior SMID biotech analysts here at the bank. It's my pleasure to have our next presenting company, Amicus Therapeutics, for the next half hour or so. Sitting next to me is President and current COO, but incoming CEO, Brad Campbell. Brad, welcome.
Bradley L. Campbell - Amicus Therapeutics, Inc. - President, COO & Director
Thank you. It's nice to see you in-person for the first time in years.
Questions and Answers:
Tazeen Ahmad - BofA Securities, Research Division - MD in Equity Research & Research AnalystYes, we're back live after 3 years. So maybe let's just start off with an overview of the company, for those who might not be as familiar. And from there, we can maybe go into some more detailed questions on the many things that are happening at the company.
Bradley L. Campbell
Trustpilot
